Title Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes /
Authors Anastasopoulou, Stavroula ; Nielsen, Rikke Linnemann ; Als-Nielsen, Bodil ; Banerjee, Joanna ; Eriksson, Mats A ; Helenius, Marianne ; Heyman, Mats M ; Johannsdottir, Inga Maria ; Jonsson, Olafur Gisli ; MacGregor, Stuart ; Mateos, Marion K ; Mayoh, Chelsea ; Mikkel, Sirje ; Myrberg, Ida Hed ; Niinimäki, Riitta ; Schmiegelow, Kjeld ; Taskinen, Mervi ; Vaitkevičienė, Goda Elizabeta ; Warnqvist, Anna ; Wolthers, Benjamin ; Harila-Saari, Arja ; Ranta, Susanna
DOI 10.3324/haematol.2021.280016
Full Text Download
Is Part of Haematologica.. Pavia : Ferrata Storti Foundation. 2022, vol. 107, no. 10, p. 2318-2327.. ISSN 0390-6078. eISSN 1592-8721
Abstract [eng] Central nervous system (CNS) toxicity is common at diagnosis and during treatment of pediatric acute lymphoblastic leukemia (ALL). We studied CNS toxicity in 1, 464 children aged 1.0-17.9 years, diagnosed with ALL and treated according to the Nordic Society of Pediatric Hematology and Oncology ALL2008 protocol. Genome-wide association studies, and a candidate single-nucleotide polymorphism (SNP; n=19) study were performed in 1, 166 patients. Findings were validated in an independent Australian cohort of children with ALL (n=797) in whom two phenotypes were evaluated: diverse CNS toxicities (n=103) and methotrexate-related CNS toxicity (n=48). In total, 135/1, 464 (9.2%) patients experienced CNS toxicity for a cumulative incidence of 8.7% (95% confidence interval: 7.31-10.20) at 12 months from diagnosis. Patients aged ≥10 years had a higher risk of CNS toxicity than had younger patients (16.3% vs. 7.4%; P<0.001). The most common CNS toxicities were posterior reversible encephalopathy syndrome (n=52, 43 with seizures), sinus venous thrombosis (n=28, 9 with seizures), and isolated seizures (n=16). The most significant SNP identified by the genome-wide association studies did not reach genomic significance (lowest P-value: 1.11x10-6), but several were annotated in genes regulating neuronal functions. In candidate SNP analysis, ATXN1 rs68082256, related to epilepsy, was associated with seizures in patients <10 years (P=0.01). ATXN1 rs68082256 was validated in the Australian cohort with diverse CNS toxicities (P=0.04). The role of ATXN1 as well as the novel SNP in neurotoxicity in pediatric ALL should be further explored.
Published Pavia : Ferrata Storti Foundation
Type Journal article
Language English
Publication date 2022
CC license CC license description